Systemic Immunomodulatory Treatments for Atopic Dermatitis

Autor: Aaron M. Drucker, Deanna E. Morra, David Prieto-Merino, Alexandra G. Ellis, Zenas Z. N. Yiu, Bram Rochwerg, Sonya Di Giorgio, Bernd W. M. Arents, Tim Burton, Phyllis I. Spuls, Jochen Schmitt, Carsten Flohr

Publikováno v: Drucker, A M, Morra, D E, Prieto-Merino, D, Ellis, A G, Yiu, Z Z N, Rochwerg, B, Di Giorgio, S, Arents, B W M, Burton, T, Spuls, P I, Schmitt, J & Flohr, C 2022, ' Systemic Immunomodulatory Treatments for Atopic Dermatitis : Update of a Living Systematic Review and Network Meta-analysis ', JAMA dermatology . https://doi.org/10.1001/jamadermatol.2022.0455
JAMA dermatology, 158(5), 523-532. American Medical Association
Drucker, A M, Morra, D E, Prieto-Merino, D, Ellis, A G, Yiu, Z Z N, Rochwerg, B, di Giorgio, S, Arents, B W M, Burton, T, Spuls, P I, Schmitt, J & Flohr, C 2022, ' Systemic Immunomodulatory Treatments for Atopic Dermatitis : Update of a Living Systematic Review and Network Meta-analysis ', Jama dermatology, vol. 158, no. 5, pp. 523-532 . https://doi.org/10.1001/jamadermatol.2022.0455
Jama dermatology, 158(5), 523-532. American Medical Association

Importance: Systemic treatments for atopic dermatitis are being evaluated primarily in placebo-controlled trials; network meta-analysis can provide relative efficacy and safety estimates for treatments that have not been compared head to head.Objecti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bdc980207951ca209184d2502f8f1f4
http://www.scopus.com/inward/record.url?scp=85127537354&partnerID=8YFLogxK

Predictors of response to anti‐IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phaseIIclinical trial data

Autor: Craig Tendler, Mary Guilfoyle, Frits van Rhee, David C. Fajgenbaum, Dustin Shilling, Sepideh Nemat, Carlos Appiani, Deanna E Morra, Sheila K Pierson

Publikováno v: Br J Haematol

Siltuximab is the only US Food and Drug Administration-approved treatment for idiopathic multicentric Castleman disease (iMCD), a rare haematological disorder associated with substantial morbidity and mortality. Although siltuximab induces a response

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e09c2693ab92996e4d703deef7d2c62c
https://doi.org/10.1111/bjh.15588

Trial registration in pediatric surgery trials

Autor: Deanna E. Morra, Lauren E. Kelly, Lisa M. Askie, Sana Rokhsefat, Martin Offringa

Publikováno v: Journal of pediatric surgery. 53(7)

Background Prospective clinical trial registration serves to increase transparency and to mitigate selective reporting bias. An assessment of adult surgical trials revealed poor trial registration practice with incomplete provision of information in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a48ba3b725c0b1429512bc768c34e3c5
https://pubmed.ncbi.nlm.nih.gov/29150369